Amneal Pharmaceuticals (AMRX) Change in Intangibles (2017 - 2026)

Amneal Pharmaceuticals' Change in Intangibles history runs 10 years deep, the most recent figure standing at $7.8 million for Q1 2026.

• In Q1 2026, Change in Intangibles rose 86.9% year-over-year to $7.8 million; the TTM figure through Mar 2026 stood at $19.2 million (up 109.44% YoY), while the FY2025 annual figure was $15.5 million, up 5.9% from the prior year.
• Change in Intangibles was $7.8 million for Q1 2026 at Amneal Pharmaceuticals, up from $3.0 million in the prior quarter.
• In the past five years, Change in Intangibles ranged from a high of $31.8 million in Q3 2022 to a low of $338000.0 in Q1 2023.
• Historically, Change in Intangibles has averaged $6.8 million across 5 years, with a median of $3.6 million in 2024.
• Biggest YoY gain for Change in Intangibles was 2769.82% in 2024; the steepest drop was 96.98% in 2024.
• A 5-year view of Change in Intangibles shows it stood at $31.8 million in 2022, then tumbled by 37.42% to $19.9 million in 2023, then sank by 96.98% to $600000.0 in 2024, then jumped by 400.0% to $3.0 million in 2025, then surged by 161.67% to $7.8 million in 2026.
• The last three Change in Intangibles figures came in at $7.8 million (Q1 2026), $3.0 million (Q4 2025), and $7.4 million (Q3 2025), per Business Quant data.